Showing 1 - 10 of 102
Korat on high alert amid concerns of Zika outbreak
News, Prasit Tangprasert, Published on 16/01/2024
» Nakhon Ratchasima: The province's public health authorities are bracing for a possible Zika virus outbreak, as at least 19 people have been infected across the lower Northeast region, the Office of Disease Prevention and Control for the 9th Region said on Monday.
Zika cases prompt health alert
Published on 12/12/2023
» Residents of Prachuap Khiri Khan are being warned to remain cautious after six cases of the Zika virus were diagnosed in the province.
Zika cases climb to 110
News, Apinya Wipatayotin, Published on 28/07/2023
» A total of 110 people have been infected with the mosquito-borne Zika virus since January, and the number of infections has been rising since May, according to the Public Health Ministry.
Dealing with dengue, Zika
Oped, Editorial, Published on 28/07/2023
» Concern over an increase in mosquito-borne disease cases deserves more attention from our government and broader society.
110 people infected with Zika since January
Online Reporters, Published on 27/07/2023
» A total of 110 people have been infected with the mosquito-borne Zika virus since January this year and the number of infections has continued rising since May, according to the Public Health Ministry.
Dengue vaccine pioneer in search of salvation
News, Karnjana Karnjanatawe, Published on 30/05/2022
» It is a combination of boundless scientific curiosity and an unflagging desire to save lives that has kept Prof Emeritus Dr Sutee Yoksan, 72, working on research and development of vaccines against mosquito-borne diseases for more than 40 years.
AstraZeneca’s and mRNA vaccines provide equivalent protection against COVID-19 hospitalisation and deaths
Published on 29/04/2022
» AstraZeneca’s COVID-19 vaccine and mRNA COVID-19 vaccines, the world’s most-used vaccines, provide equivalent protection against hospitalisation and death from COVID-19 following two doses, a new expert review of data from 79 real-world studies reveals.
Potential Impact of Takeda’s Dengue Vaccine Candidate Reinforced by Long-Term Safety and Efficacy Results
Published on 24/05/2021
» •Takeda’s dengue vaccine candidate (TAK-003) prevented 83.6% of hospitalizations and 62.0% of dengue illness overall, with no identified important safety risks through three years following vaccination in ongoing pivotal Phase 3 TIDES trial • Regulatory filings for TAK-003 progressing in European Union and in many dengue-endemic countries; filing in United States planned for later this year • Dengue is the fastest-spreading mosquito-borne viral disease with an estimated 390 million cases and 500,000 hospitalizations per year globally, with limited options for prevention
Takeda Begins Regulatory Submissions for Dengue Vaccine Candidate in EU and Dengue-Endemic Countries
Published on 30/03/2021
» Takeda Begins Regulatory Submissions for Dengue Vaccine Candidate in EU and Dengue-Endemic Countries
Blocking Zika virus maternal-to-fetal transmission using innovative “organ in a dish”
Published on 21/10/2020
» In February 2016, the World Health Organisation declared the mosquito-borne Zika virus a Public Health Emergency of International Concern (PHEIC). The declaration was driven by concern over links between the disease and neonatal neurological disorders, including microcephaly, a birth defect where a baby is born with a significantly smaller head than normal.